Log in
About us
Join
Donate
Contact us
Home
Membership
Join Today!
Members Only
IANS in Europe
Spanish/Portuguese Corner
DARE and HRA Documentos
IANS in Asia
Certification Program
Education
Registration
WebRounds Schedule 2026
Growing the Workforce Seminar Series
Virtual Standard HRA Course 2026
Registration Rate
Course Program
HRA Course Faculty
CME
HRA Q&A Forum
Virtual Advanced HRA Course 2026
Registration Rate
Course Program
Advanced HRA Course Faculty
CME
Advanced HRA Q&A Forum
IANS HRA Hands-on Course 2026
Registration
Hands-on Program
Hotel Accommodations
Scientific Meeting 2026
Registration Details and Fees
Venue & Travel
Abstracts 2026
Abstract Terms and Conditions
Past Abstract Publication
How to be a Sponsor or Exhibitor
Exhibiting Prospectus
Sponsor Opportunities
Additional Support Opportunities
Meeting Program
IANS Social Activities
Past Scientific Meeting Photos
Other Courses
Pathology
Pathology PowerPoint - p16 Immunoreactivity
Pathology PowerPoint - Classifying AIN2 Lesions
Pathology PowerPoint - Reading between the lines - Helpful hints in understanding pathology reports
Provider Screening Hub
Introduction to the screening tool kit
Whom and How to Screen
Introduction Who and How to Screen
Summary IANS Guidelines
Screening Population Table
Anal Cytology and DARE
Anal Cytology Supplies and Methods
Anal Cytology Collection Video
DARE Intro
DARE Video
Patient Education
Patient Education Flyers
Sample Flyer 1
Sample Flyer 2
Sample Flyer 3
Web Resources
Frequently Asked Questions
HRA Referral
HRA Referral introduction
HRA Referral list
Translated Resources
Patient Support
Basic Facts
Resource Materials
General Info on HPV
HPV Immunization
General Info on Anal Cancer and Precancer
Info Related to Procedures
Resource Sites and Organizations
Support Services
Patient Seminars
About Us
Board of Directors
IANS Committees
Mission Statement
Bylaws
IANS Financials
Career Center
Job Post Subscription
Reply to: Patients of Transgender Experience Following DX of Anal Cancer
*
Mandatory
fields
Author
Body
<blockquote><strong class="quote">Anonymous wrote:</strong> <P>Are there any concerns for restarting hormone therapies following treatment for anal cancer? </P> <P>John Stanton, DNP, MPH, AGPCN-BC, AAHIVS</P> </blockquote><br>
You can use basic HTML tags.
Contact us
Powered by
Wild Apricot
Membership Software
